It's quick, safe, and relatively painless, and if interventional radiologists want to own it, they'd better step up quickly: Endovenous laser treatment of varicose veins is poised to take off, according to researchers at Cornell University. A two-year follow-up of 97 treated limbs showed a 6% recurrence rate, compared with 10% or higher recurrence that was reported for surgery, radio-frequency ablation, and transcatheter sclerotherapy.
It's quick, safe, and relatively painless, and if interventional radiologists want to own it, they'd better step up quickly: Endovenous laser treatment of varicose veins is poised to take off, according to researchers at Cornell University. A two-year follow-up of 97 treated limbs showed a 6% recurrence rate, compared with 10% or higher recurrence that was reported for surgery, radio-frequency ablation, and transcatheter sclerotherapy.
The U.S. study was presented at this year's 15th annual International Symposium on Endovascular Therapy. It showed that laser treatment can be performed in an outpatient setting.
"Most of the people qualified to perform this procedure should be interventional radiologists, but over the next couple of years there will be thousands of physicians doing it, including vascular and general surgeons and even dermatologists," said Dr. Robert Min, coauthor and director of Cornell's new vascular center.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.